Table 1.
Clinical and epidemiological characteristics of hospitalized COVID-19 patients (n = 1553).
| Characteristics | n (%) | ||
|---|---|---|---|
| Vaccinated | |||
| Unvaccinated | 1480 (95.2) | ||
| Only the first dose | 43 (2.8) | ||
| First and second dose | 31 (2.0) | ||
| Vaccine type | |||
| Pfizer | 64 (86.5) | ||
| Sinopharm | 8 (10.8) | ||
| AstraZeneca | 2 (2.7) | ||
| Age (years) * | 55.2 ± 16.8 | ||
| Sex | |||
| Female | 647 (41.6) | ||
| Male | 907 (58.4) | ||
| Medical insurance | |||
| SIS | 899 (57.8) | ||
| EsSalud | 152 (9.8) | ||
| Others | 26 (1.7) | ||
| No medical insurance | 477 (30.7) | ||
| Symptoms at the onset of the disease | |||
| Dyspnea | |||
| No | 706 (45.5) | ||
| Yes | 847 (54.5) | ||
| Fever | |||
| No | 989 (63.7) | ||
| Yes | 564 (36.3) | ||
| Cough | |||
| No | 411 (26.5) | ||
| Yes | 1142 (73.5) | ||
| Comorbidity | |||
| Hypertension ** | |||
| No | 1454 (93.7) | ||
| Yes | 97 (6.3) | ||
| Type 2 diabetes ** | |||
| No | 1521 (98.1) | ||
| Yes | 30 (1.9) | ||
| Chronic kidney disease ** | |||
| No | 1533 (98.8) | ||
| Yes | 18 (1.2) | ||
| Obesity ** | |||
| No | 1516 (97.7) | ||
| Yes | 35 (2.3) | ||
| Cancer ** | |||
| No | 1516 (97.7) | ||
| Breast | 10 (0.65) | ||
| Cervical | 3 (0.19) | ||
| Prostate | 3 (0.19) | ||
| Stomach | 2 (0.13) | ||
| Brain | 2 (0.13) | ||
| Non-Hodgkin’s lymphoma | 2 (0.13) | ||
| Unspecified or uncommon site | 13 (0.83) | ||
| Neurological * | |||
| No | 1526 (98.4) | ||
| Yes | 25 (1.6) | ||
| Death after 28 days | 592 (38.1) | ||
| Death after 90 days | 614 (39.5) | ||
* Mean ± standard deviation. ** Some variables can have missing data. SIS: Seguro Integral de Salud.